Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients

BACKGROUND: Immune checkpoint blockade has emerged as a highly effective treatment for patients with metastatic melanoma and cutaneous squamous cell carcinoma. Nivolumab blocks the interactions between programmed cell death protein 1 and programmed death ligand 1 allowing for activation of a latent...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Immunother Cancer
Glavni autori: Trager, Megan H, Coley, Shana M, Dube, Geoffrey, Khan, Shaheer, Ingham, Matthew, Samie, Faramarz H, Geskin, Larisa J, McDonnell, Diana, Brouder, Daniel, Saenger, Yvonne, Carvajal, Richard
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2020
Teme:
Case Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279669/
https://ncbi.nlm.nih.gov/pubmed/32503950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000908
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items